HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Galantucci Selected Research

4-Nle-7-Phe-alpha- MSH

7/2010Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism.
8/2009Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268.
3/2009Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Galantucci Research Topics

Disease

7Brain Ischemia (Cerebral Ischemia)
05/2013 - 05/2006
7Ischemic Stroke
04/2012 - 05/2006
5Stroke (Strokes)
11/2011 - 05/2006
4Myocardial Ischemia (Ischemic Heart Diseases)
06/2013 - 03/2009
3Ischemia
06/2013 - 07/2010
3Shock
04/2012 - 03/2009
2Inflammation (Inflammations)
03/2014 - 09/2013
2Alzheimer Disease (Alzheimer's Disease)
03/2014 - 09/2013
2Infarction (Infarctions)
06/2013 - 07/2010
2Necrosis
02/2011 - 07/2010
1Cognitive Dysfunction
10/2014
1Dementia (Dementias)
03/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2014
1Myocardial Infarction
06/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012
1Hemorrhagic Shock
03/2012
1Osteosarcoma (Osteogenic Sarcoma)
03/2012
1Hemorrhage
03/2012
1Multiple Organ Failure (MODS)
02/2011

Drug/Important Bio-Agent (IBA)

14MelanocortinsIBA
10/2014 - 05/2006
6Melanocyte-Stimulating Hormones (MSH)IBA
03/2014 - 02/2011
5Peptides (Polypeptides)IBA
04/2012 - 05/2006
4Phosphotransferases (Kinase)IBA
09/2013 - 07/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013 - 07/2010
4alpha-MSHIBA
07/2010 - 05/2006
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2013 - 07/2010
3Caspase 3 (Caspase-3)IBA
09/2013 - 07/2010
34-Nle-7-Phe-alpha- MSHIBA
07/2010 - 03/2009
2Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
10/2014 - 05/2013
2Adrenocorticotropic Hormone (ACTH)FDA Link
06/2013 - 04/2012
2Bromodeoxyuridine (BrdU)IBA
05/2013 - 10/2011
2Neuroprotective AgentsIBA
11/2011 - 03/2009
2Cholinergic Agents (Cholinergics)IBA
07/2010 - 03/2009
2Endothelin-1 (Endothelin 1)IBA
03/2009 - 09/2007
1Biomarkers (Surrogate Marker)IBA
03/2014
1Amyloid (Amyloid Fibrils)IBA
03/2014
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
09/2013
1tau Proteins (tau Protein)IBA
09/2013
1Cosyntropin (Cortrosyn)FDA LinkGeneric
06/2013
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
06/2013
1U 0126 (UO 126)IBA
06/2013
1EnzymesIBA
06/2013
1Proteins (Proteins, Gene)FDA Link
06/2013
1Transcription Factors (Transcription Factor)IBA
06/2013
1Apoptosis Regulatory ProteinsIBA
06/2013
1Heme Oxygenase-1IBA
06/2013
1CateninsIBA
05/2013
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
03/2012
1Activating Transcription Factor 3IBA
03/2012
1LipopolysaccharidesIBA
02/2011
1ZymosanIBA
02/2011
1Chlorisondamine (Chlorisondamine Chloride)IBA
02/2011
1salicylhydroxamic acid (SHAM)IBA
02/2011
1Messenger RNA (mRNA)IBA
02/2011
1Interleukin-10 (Interleukin 10)IBA
02/2011
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
02/2011
1Tumor Biomarkers (Tumor Markers)IBA
07/2010
1NeuropeptidesIBA
05/2006

Therapy/Procedure

2Ligation
06/2013 - 07/2010
2Treatment Delay
08/2009 - 09/2007
1Aftercare (After-Treatment)
09/2013
1Heart Transplantation (Grafting, Heart)
04/2012
1General Anesthesia
03/2012
1Intraperitoneal Injections
02/2011